Global HER2 Inhibitors Market - Industry Trends and Forecast to 2028

시장 분석 및 통찰력 : 글로벌 HER2 억제제 시장

HER2 억제제 시장은 2021년부터 2028년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 위에 언급된 예측 기간 동안 시장이 9%의 CAGR로 성장할 것으로 분석합니다.

인간 상피 성장 인자 수용체(HER2) 억제제는 티로신 키나제 억제제 또는 단일 클론 항체로 세포 성장을 늦추거나 멈추어 암 성장 위험을 줄입니다. 인간 상피 성장 인자 수용체는 막관통 수용체, 세포 외 구성 요소 및 세포 내 티로신 키나제 구성 요소를 갖는 막관통 수용체입니다. 

유방암과 위암의 유병률 증가는 시장 성장을 가속화할 주요 요인입니다. 또한, 의료비 지출 증가, 연구 활동에 대한 투자 증가, 정부 자금 지원 증가, 정부와 민간 기관의 암에 대한 인식 확산을 위한 이니셔티브 증가는 HER2 억제제 시장을 확대할 요인입니다.

2021~2028년 예측 기간 동안 연구 개발 활동이 증가하고 승인된 HER2 억제제 판매가 급증함에 따라 HER2 억제제 시장에 유익한 기회가 제공될 것입니다.

그러나 높은 치료 비용, HER2 억제제의 부작용, 허셉틴 바이오시밀러 출시에 대한 불확실성, 대체 치료 옵션의 존재는 시장을 제약하는 요소로 작용하여 위에서 언급한 예측 기간 동안 HER2 억제제 시장에 더 큰 어려움을 초래할 것입니다.

This HER2 inhibitors market  report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the HER2 inhibitors market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global HER2 Inhibitors Market Scope and Market Size

The HER2 inhibitors market is segmented on the basis of treatment, application, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of treatment, the HER2 inhibitors market is segmented into monotherapy and combination therapy.
• On the basis of application, the HER2 inhibitors market is segmented into squamous cell carcinoma, gastric cancer, adenocarcinoma, breast cancer, large cell carcinoma and others.
• On the basis of end-users, the HER2 inhibitors market is segmented into clinic, hospital and others.

The HER2 inhibitors market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

HER2 Inhibitors Market Country Level Analysis

HER2 inhibitors market is analyzed and market size information is provided by the country, treatment, application, end-users and distribution channel as referenced above.

The countries covered in the HER2 inhibitors market  report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the HER2 inhibitors market due to the presence of major key players, high sale of approved HER2 inhibitors due to rising prevalence of breast cancer, high healthcare expenditure and well-developed healthcare sector in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, increasing incidence of cancer, rising investment in the healthcare sector and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

HER2 inhibitors market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global HER2 Inhibitors Market Share Analysis

HER2 inhibitors market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to HER2 inhibitors market research.

The major players covered in the HER2 inhibitors market report are Biocon, F. Hoffmann-La Roche Ltd., AbbVie Inc., Merck Sharp & Dohme Corp., Novartis AG, Mylan N.V., Puma Biotechnology, Inc., Pfizer Inc., Boehringer Ingelheim International GmbH., Johnson & Johnson Private Limited, Genentech, Inc., GlaxoSmithKline plc, among other domestic and global players.  Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

SKU-66358